Audentes Therapeutics Announces New Data To Be Presented At American Society Of Cell And Gene Therapy Annual Meeting

SAN FRANCISCO--(BUSINESS WIRE)--Audentes Therapeutics, Inc., a biotechnology company committed to the development and commercialization of gene therapy products for patients with serious, rare diseases, today announced that new data from its lead development programs will be presented at the 18th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT), to be held in New Orleans, Louisiana on May 13-16th, 2015.

Help employers find you! Check out all the jobs and post your resume.